Treating diabetes to accepted standards of care: A 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States

This publication has 31 references indexed in Scilit:

• Economic Costs of Diabetes in the U.S. in 2002
  Diabetes Care, 2003
• The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the Aace System of Intensive Diabetes Self-Management—2002 Update
  Endocrine Practice, 2002
• Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
  BMJ, 2001
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• DIABETIC COMPLICATIONS
  Endocrinology and Metabolism Clinics of North America, 1996
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
  Diabetes Research and Clinical Practice, 1995
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
  Diabetes Care, 1995
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus
  New England Journal of Medicine, 1993
• Long-term glycemie control and kidney function in insulin-dependent diabetes mellitus
  Kidney International, 1992